계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Perseus-Soros Biopharmaceutical Fund
investment firm
Investments
Number of Investments
Number of Lead Investments
22
5
Perseus-Soros Biopharmaceutical Fund has made 22 investments. Their most recent investment was on
Oct 30, 2009, when Xanodyne, Inc raised
| Date | Company Name | Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|---|
| Oct 30, 2009 | Xanodyne | Series Unknown | — | Biotechnology | — |
| Sep 29, 2008 | CeNeRx BioPharma | Series B | — | Biopharma | — |
| Nov 14, 2007 | Ambit Biosciences | Series D | — | Biopharma | — |
| May 1, 2006 | Cardiokine | Series B | — | Biotechnology | — |
| Apr 12, 2006 | SkinMedica | Series E | — | Biotechnology | — |
| Nov 14, 2005 | CeNeRx BioPharma | Series A | — | Biopharma | — |
| May 12, 2005 | Ambit Biosciences | Series C | — | Biopharma | — |
| Apr 6, 2005 | SkinMedica | Series E | — | Biotechnology | — |
| Mar 2, 2005 | ArgiNOx Phamaceuticals | Series C | — | Biotechnology | — |
| Aug 5, 2004 | Just Kratom Store | Series C | — | Health Care | Yes |
| Jul 14, 2004 | SkinMedica | Series D | — | Biotechnology | Yes |
| Jun 12, 2004 | ArgiNOx Phamaceuticals | Series B | — | Biotechnology | — |
| Apr 13, 2004 | Cardiokine | Series A | — | Biotechnology | Yes |
| Nov 7, 2003 | Auxilium Pharmaceuticals | Series D | — | Biotechnology | — |
| Aug 29, 2003 | Myogen | Series D | — | Biopharma | — |
| Jan 10, 2003 | Aton Pharma | Private Equity（PE） | — | Biotechnology | — |
| Oct 22, 2002 | Oculex Pharmaceuticals | Series B | — | Biotechnology | Yes |
| May 9, 2002 | Advion Inc. | Series B | — | Biotechnology | Yes |
| Jan 3, 2002 | Myogen | Series D | — | Biopharma | — |
| Oct 17, 2001 | GeneFormatics | Series Unknown | — | Biotechnology | — |
| Oct 9, 2001 | Aderis Pharmaceuticals | Series D | — | Biopharma | — |
| Dec 31, 2000 | Ambit Biosciences | Series B | — | Biopharma | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
